{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:44:00Z","timestamp":1775151840917,"version":"3.50.1"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Genome BC, Genome Canada and Canadian Institutes of Health Research (CIHR) Partnership in Genomics"},{"name":"Personalized Health","award":["142HIV"],"award-info":[{"award-number":["142HIV"]}]},{"name":"CIHR operating grant","award":["HOP-111406"],"award-info":[{"award-number":["HOP-111406"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.virusres.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T06:15:54Z","timestamp":1482041754000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Promises and pitfalls of Illumina sequencing for HIV resistance genotyping"],"prefix":"10.1016","volume":"239","author":[{"given":"Chanson J.","family":"Brumme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Art F.Y.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2016.12.008_bib0005","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1038\/ncomms8256","article-title":"Analysis of deletion breakpoints from 1092 humans reveals details of mutation mechanisms","volume":"6","author":"Abyzov","year":"2015","journal-title":"Nat. Commun."},{"issue":"Suppl. 5","key":"10.1016\/j.virusres.2016.12.008_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2105-14-S5-S1","article-title":"Discovering motifs that induce sequencing errors","volume":"14","author":"Allhoff","year":"2013","journal-title":"BMC Bioinf."},{"issue":"July (12)","key":"10.1016\/j.virusres.2016.12.008_bib0015","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1093\/nar\/gks251","article-title":"Grinder: a versatile amplicon and shotgun sequence simulator","volume":"40","author":"Angly","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"10.1016\/j.virusres.2016.12.008_bib0020","doi-asserted-by":"crossref","first-page":"e49602","DOI":"10.1371\/journal.pone.0049602","article-title":"Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism","volume":"7","author":"Archer","year":"2012","journal-title":"PLoS One"},{"issue":"June (9)","key":"10.1016\/j.virusres.2016.12.008_bib0025","doi-asserted-by":"crossref","first-page":"F83","DOI":"10.1097\/00002030-200006160-00001","article-title":"A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy","volume":"14","author":"Baxter","year":"2000","journal-title":"AIDS"},{"issue":"28","key":"10.1016\/j.virusres.2016.12.008_bib0030","doi-asserted-by":"crossref","first-page":"16948","DOI":"10.1016\/S0021-9258(19)84799-3","article-title":"Specificity and mechanism of error-prone replication by human immunodeficiency virus-1 reverse transcriptase","volume":"264","author":"Bebenek","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.virusres.2016.12.008_bib0035","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1093\/nar\/gkg575","article-title":"Geno2pheno: estimating phenotypic drug resistance from HIV-1 genotypes","volume":"31","author":"Beerenwinkel","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"Suppl. 2","key":"10.1016\/j.virusres.2016.12.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/135965350801302S03","article-title":"The World Health Organization\u2019s global strategy for prevention and assessment of HIV drug resistance","volume":"13","author":"Bennett","year":"2008","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0045","doi-asserted-by":"crossref","first-page":"e4724","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"issue":"7218","key":"10.1016\/j.virusres.2016.12.008_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature07517","article-title":"Accurate whole human genome sequencing using reversible terminator chemistry","volume":"456","author":"Bentley","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/135965350701200114","article-title":"HIV-1 drug resistance surveillance using dried whole blood spots","volume":"12","author":"Bertagnolio","year":"2007","journal-title":"Antivir. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.virusres.2016.12.008_bib0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/135965350801302S05","article-title":"World Health Organization\/HIVResNet drug resistance laboratory strategy","volume":"13","author":"Bertagnolio","year":"2008","journal-title":"Antivir. Ther."},{"issue":"10","key":"10.1016\/j.virusres.2016.12.008_bib0065","doi-asserted-by":"crossref","first-page":"e76935","DOI":"10.1371\/journal.pone.0076935","article-title":"Evaluation of alignment algorithms for discovery and identification of pathogens using RNA-Seq","volume":"8","author":"Borozan","year":"2013","journal-title":"PLoS One."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0070","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/gb-2014-15-3-r53","article-title":"An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge","volume":"15","author":"Brownstein","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.virusres.2016.12.008_bib0075","series-title":"21st Conference on Retroviruses and Opportunistic Infections","article-title":"Within-Run cross-Contamination in deep sequencing applications on the Illumina MiSeq","author":"Brumme","year":"2014"},{"issue":"December (6)","key":"10.1016\/j.virusres.2016.12.008_bib0080","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/jac\/dkn412","article-title":"Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance","volume":"62","author":"Buckton","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0085","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1128\/CMR.00074-09","article-title":"Validation of laboratory-developed molecular assays for infectious diseases","volume":"23","author":"Burd","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"10","key":"10.1016\/j.virusres.2016.12.008_bib0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1002314","article-title":"Deep molecular characterization of HIV-1 dynamics under suppressive HAART","volume":"7","author":"Buz\u00f3n","year":"2011","journal-title":"PLoS Pathog."},{"issue":"January (3)","key":"10.1016\/j.virusres.2016.12.008_bib0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.283.3.381","article-title":"Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel","volume":"283","author":"Carpenter","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/QAD.0b013e3283367796","article-title":"High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors","volume":"24","author":"Charpentier","year":"2010","journal-title":"AIDS"},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0105","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.00650-15","article-title":"Development and validation of two screening assays for the hepatitis C virus NS3 Q80\u2009K polymorphism associated with reduced response to combination treatment regimens containing simeprevir","volume":"53","author":"Chui","year":"2015","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0110","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2353\/jmoldx.2006.050148","article-title":"Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D","volume":"8","author":"Church","year":"2006","journal-title":"J. Mol. Diagn."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0115","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00002030-200202150-00008","article-title":"Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA)","volume":"16","author":"Cingolani","year":"2002","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.virusres.2016.12.008_bib0120","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/nbt.1975","article-title":"Performance comparison of exome DNA sequencing technologies","volume":"29","author":"Clark","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bioinformatics\/btp614","article-title":"The GNUMAP algorithm: unbiased probabilistic mapping of oligonucleotides from next-generation sequencing","volume":"26","author":"Clement","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virusres.2016.12.008_bib0130","series-title":"Molecular Diagnostic Methods for Infectious Diseases. CLSI Report MM03","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.virusres.2016.12.008_bib0135","series-title":"Molecular Diagnostic Methods for Infectious Diseases. CLSI Report MM03","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"issue":"February (2)","key":"10.1016\/j.virusres.2016.12.008_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/AAC.43.2.199","article-title":"Genetic methods for assessing antimicrobial resistance","volume":"43","author":"Cockerill","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5197","key":"10.1016\/j.virusres.2016.12.008_bib0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1126\/science.7824947","article-title":"HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy","volume":"267","author":"Coffin","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0150","doi-asserted-by":"crossref","first-page":"e10588","DOI":"10.1371\/journal.pone.0010588","article-title":"Rhinovirus genome evolution during experimental human infection","volume":"5","author":"Cordey","year":"2010","journal-title":"PLoS One"},{"issue":"October (3)","key":"10.1016\/j.virusres.2016.12.008_bib0155","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/jac\/dku426","article-title":"Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multi-cohort European case-control study using centralized ultrasensitive 454 sequencing","volume":"70","author":"Cozzi-Lepri","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"issue":"12","key":"10.1016\/j.virusres.2016.12.008_bib0160","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cancergen.2013.11.005","article-title":"Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data sets","volume":"206","author":"Daber","year":"2013","journal-title":"Cancer Genet."},{"issue":"March (1)","key":"10.1016\/j.virusres.2016.12.008_bib0165","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/135965350000500112","article-title":"The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan","volume":"5","author":"DeGruttola","year":"2000","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0170","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.806","article-title":"A framework for variation discovery and genotyping using next-generation DNA sequencing data","volume":"43","author":"DePristo","year":"2011","journal-title":"Nat. Genet."},{"issue":"September (16)","key":"10.1016\/j.virusres.2016.12.008_bib0175","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1093\/nar\/gkn425","article-title":"Substantial biases in ultra-short read data sets from high-throughput DNA sequencing","volume":"36","author":"Dohm","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"9171","key":"10.1016\/j.virusres.2016.12.008_bib0180","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(98)12291-2","article-title":"Drug-resistance genotyping in HIV-1 therapy: The VIRADAPT randomized controlled trial","volume":"353","author":"Durant","year":"1999","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog."},{"issue":"Suppl. 16","key":"10.1016\/j.virusres.2016.12.008_bib0190","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1186\/1471-2105-15-S16-S15","article-title":"Verification and validation of bioinformatics software without a gold standard: a case study of BWA and Bowtie","volume":"15","author":"Giannoulatou","year":"2014","journal-title":"BMC Bioinf."},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0195","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1128\/AAC.02710-13","article-title":"Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism","volume":"58","author":"Gibson","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9534","key":"10.1016\/j.virusres.2016.12.008_bib0200","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"Gilks","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0205","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1755-0998.2011.03024.x","article-title":"Field guide to next-generation DNA sequencers","volume":"11","author":"Glenn","year":"2011","journal-title":"Mol. Ecol. Resour."},{"key":"10.1016\/j.virusres.2016.12.008_bib0210","series-title":"International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies","article-title":"A fully integrated and simplified HIV clinical genotyping solution using 454 ultra deep sequencing and the DeepChek\u2122-HIV system","author":"Gonzalez","year":"2011"},{"key":"10.1016\/j.virusres.2016.12.008_bib0215","series-title":"21st Conference on Retroviruses and Opportunistic Infections","article-title":"A proposed HIV reference sample characterized by three next generation sequencing platforms","author":"Gonzalez-Serna","year":"2014"},{"key":"10.1016\/j.virusres.2016.12.008_bib0220","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1186\/1471-2164-13-666","article-title":"The effect of strand bias in Illumina short-read sequencing data","volume":"13","author":"Guo","year":"2012","journal-title":"BMC Genomics"},{"issue":"9849","key":"10.1016\/j.virusres.2016.12.008_bib0225","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(12)61038-1","article-title":"Global trends in antiretroviral resistance in treatment-na\u00efve individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis","volume":"380","author":"Gupta","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1177\/135965350901400513","article-title":"Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review","volume":"14","author":"Hamers","year":"2009","journal-title":"Antivir. Ther."},{"issue":"10","key":"10.1016\/j.virusres.2016.12.008_bib0235","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"Hamers","year":"2011","journal-title":"Lancet Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.virusres.2016.12.008_bib0240","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cid\/cir995","article-title":"Building capacity for the assessment of HIV drug resistance: experiences from the pharmaccess African studies to evaluate resistance network","volume":"54","author":"Hamers","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.virusres.2016.12.008_bib0245","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less","volume":"337","author":"Hammer","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"February (3)","key":"10.1016\/j.virusres.2016.12.008_bib0250","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","volume":"191","author":"Harrigan","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0255","doi-asserted-by":"crossref","first-page":"e1002529","DOI":"10.1371\/journal.ppat.1002529","article-title":"Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection","volume":"8","author":"Henn","year":"2012","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0260","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1371\/journal.pmed.0030356","article-title":"Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART","volume":"3","author":"Hogg","year":"2006","journal-title":"PLoS Med."},{"issue":"February (4)","key":"10.1016\/j.virusres.2016.12.008_bib0265","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/bioinformatics\/btr708","article-title":"ART: a next-generation sequencing read simulator","volume":"28","author":"Huang","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virusres.2016.12.008_bib0270","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2016.11.008","article-title":"MinVar: a rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing","volume":"240","author":"Huber","year":"2017","journal-title":"J. Virol. Methods"},{"issue":"April (4)","key":"10.1016\/j.virusres.2016.12.008_bib0275","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nbt.2522","article-title":"Updating benchtop sequencing performance comparison","volume":"31","author":"J\u00fcnemann","year":"2013","journal-title":"Nat. Biotechnol."},{"issue":"50","key":"10.1016\/j.virusres.2016.12.008_bib0280","doi-asserted-by":"crossref","first-page":"20166","DOI":"10.1073\/pnas.1110064108","article-title":"Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID","volume":"108","author":"Jabara","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0285","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3851\/IMP1839","article-title":"Next-generation sequencing of dried blood spot specimens: a novel approach to HIV drug-resistance surveillance","volume":"16","author":"Ji","year":"2011","journal-title":"Antivir. Ther."},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0056170","article-title":"Pyrosequencing dried blood spots reveals differences in HIV drug resistance between treatment Na\u00efve and experienced patients","volume":"8","author":"Ji","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.virusres.2016.12.008_bib0295","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-na\u00efve populations and associate with reduced treatment efficacy","volume":"5","author":"Johnson","year":"2008","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0300","first-page":"6","article-title":"Update of the drug resistance mutations in HIV-1: March 2013","volume":"21","author":"Johnson","year":"2013","journal-title":"Top Antivir Med."},{"issue":"Suppl. 2","key":"10.1016\/j.virusres.2016.12.008_bib0305","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350801302S07","article-title":"World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites","volume":"13","author":"Jordan","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.virusres.2016.12.008_bib0310","unstructured":"Montaner, J.S.G., Guillemi, S., Harris, M., BC Centre for Excellence in HIV\/AIDS Therapeutic Guidelines Committee. Therapeutic Guidelines: Antiretroviral (ARV) Treatment of Adult HIV Infection. 2013."},{"issue":"Suppl 4","key":"10.1016\/j.virusres.2016.12.008_bib0315","first-page":"2","article-title":"Are countries using global fund support to implement HIV drug resistance surveillance? A review of funded HIV grants","volume":"54","author":"Kelley","year":"2012","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0320","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1089\/aid.2014.0031","article-title":"Primer ID informs next-generation sequencing platforms and reveals preexisting drug resistance mutations in the HIV-1 reverse transcriptase coding domain","volume":"31","author":"Keys","year":"2015","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"January (1)","key":"10.1016\/j.virusres.2016.12.008_bib0325","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.01868-10","article-title":"In vitro selection of clinically relevant bevirimat resistance mutations revealed by deep sequencing of serially passaged, quasispecies-containing recombinant HIV-1","volume":"49","author":"Knapp","year":"2011","journal-title":"J. Clin. Microbiol."},{"issue":"8","key":"10.1016\/j.virusres.2016.12.008_bib0330","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1128\/JCM.41.8.3559-3565.2003","article-title":"Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results","volume":"41","author":"Korn","year":"2003","journal-title":"J. Clin. Microbiol."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0335","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/infdis\/167.3.526","article-title":"A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients","volume":"167","author":"Kozal","year":"1993","journal-title":"J. Infect. Dis."},{"issue":"April (4)","key":"10.1016\/j.virusres.2016.12.008_bib0340","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"issue":"11","key":"10.1016\/j.virusres.2016.12.008_bib0345","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1128\/AAC.01490-15","article-title":"HIV drug resistance testing by high-Multiplex wide sequencing on the Illumina MiSeq","volume":"59","author":"Lapointe","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0350","doi-asserted-by":"crossref","first-page":"e10952","DOI":"10.1371\/journal.pone.0010952","article-title":"Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-na\u00efve subjects in the CASTLE study","volume":"5","author":"Lataillade","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0355","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/aid.2012.0338","article-title":"Comparison of population and 454 deep dequence analysis for HIV type 1 tropism versus the original Trofile assay in non-B subtypes","volume":"29","author":"Lee","year":"2013","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"12","key":"10.1016\/j.virusres.2016.12.008_bib0360","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/nbt1371","article-title":"Bioinformatics prediction of HIV coreceptor usage","volume":"25","author":"Lengauer","year":"2007","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0365","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1101\/gr.088013.108","article-title":"SNP detection for massively parallel whole-genome resequencing","volume":"19","author":"Li","year":"2009","journal-title":"Genome Res."},{"issue":"August (16)","key":"10.1016\/j.virusres.2016.12.008_bib0370","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"13","key":"10.1016\/j.virusres.2016.12.008_bib0375","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2011.375","article-title":"Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis","volume":"305","author":"Li","year":"2011","journal-title":"JAMA"},{"issue":"January (12)","key":"10.1016\/j.virusres.2016.12.008_bib0380","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1093\/nar\/gku355","article-title":"Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing","volume":"42","author":"Liang","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virusres.2016.12.008_bib0385","series-title":"8th International AIDS Society Conference on HIV Pathogenesis Treatment and Prevention","article-title":"Kive: a framework for version control of bioinformatic pipelines and data, and its application to HIV resistance genotyping","author":"Liang","year":"2015"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0390","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1755-8794-7-20","article-title":"Analytical validation of whole exome and whole genome sequencing for clinical applications","volume":"7","author":"Linderman","year":"2014","journal-title":"BMC Med. Genomics"},{"issue":"June (11)","key":"10.1016\/j.virusres.2016.12.008_bib0395","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"May (5)","key":"10.1016\/j.virusres.2016.12.008_bib0400","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nbt.2198","article-title":"Performance comparison of benchtop high-throughput sequencing platforms","volume":"30","author":"Loman","year":"2012","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0405","doi-asserted-by":"crossref","first-page":"e1002417","DOI":"10.1371\/journal.pcbi.1002417","article-title":"Highly sensitive and specific detection of rare variants in mixed viral populations from massively parallel sequence data","volume":"8","author":"Macalalad","year":"2012","journal-title":"PLoS Comput. Biol."},{"issue":"8","key":"10.1016\/j.virusres.2016.12.008_bib0410","doi-asserted-by":"crossref","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","article-title":"Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase","volume":"69","author":"Mansky","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2016.12.008_bib0415","series-title":"International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies","article-title":"A novel ambient storage and transport device for utilization in infectious disease testing: viveST\u2122","author":"McClernon","year":"2013"},{"key":"10.1016\/j.virusres.2016.12.008_bib0420","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2164-13-74","article-title":"GemSIM: general, error-model based simulator of next-generation sequencing data","volume":"13","author":"McElroy","year":"2012","journal-title":"BMC Genomics."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0425","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/1471-2164-14-501","article-title":"Accurate single nucleotide variant detection in viral populations by combining probabilistic clustering with a statistical test of strand bias","volume":"14","author":"McElroy","year":"2013","journal-title":"BMC Genomics"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2042-5783-4-1","article-title":"Deep sequencing of evolving pathogen populations: applications, errors, and bioinformatic solutions","volume":"4","author":"McElroy","year":"2014","journal-title":"Microb. Inform. Exp."},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0435","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"issue":"12","key":"10.1016\/j.virusres.2016.12.008_bib0440","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/jama.279.12.930","article-title":"A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: the INCAS Trial","volume":"279","author":"Montaner","year":"1998","journal-title":"JAMA"},{"issue":"July (13)","key":"10.1016\/j.virusres.2016.12.008_bib0445","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1093\/nar\/gkr344","article-title":"Sequence-specific error profile of Illumina sequencers","volume":"39","author":"Nakamura","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0450","doi-asserted-by":"crossref","first-page":"e24907","DOI":"10.1371\/journal.pone.0024907","article-title":"Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing","volume":"6","author":"Nasu","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrg2986","article-title":"Genotype and SNP calling from next-generation sequencing data","volume":"12","author":"Nielsen","year":"2011","journal-title":"Nat. Rev. Genet."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0460","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/gm432","article-title":"Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing","volume":"5","author":"O\u2019Rawe","year":"2013","journal-title":"Genome Med."},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0465","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/bib\/bbs086","article-title":"A survey of tools for variant analysis of next-generation genome sequencing data","volume":"15","author":"Pabinger","year":"2014","journal-title":"Brief. Bioinform."},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0470","first-page":"662","article-title":"Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure","volume":"201","author":"Paredes","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.virusres.2016.12.008_bib0475","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/QAD.0b013e3283034953","article-title":"Transmission of HIV-1 minority-resistant variants and response to first-line antiretroviral therapy","volume":"22","author":"Peuchant","year":"2008","journal-title":"AIDS"},{"issue":"18","key":"10.1016\/j.virusres.2016.12.008_bib0480","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Pham","year":"2014","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0485","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1479-7364-8-14","article-title":"Validation and assessment of variant calling pipelines for next-generation sequencing","volume":"8","author":"Pirooznia","year":"2014","journal-title":"Hum. Genomics"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0490","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5858\/arpa.2010-0623-OA","article-title":"Design and analytical validation of clinical DNA sequencing assays","volume":"136","author":"Pont-Kingdon","year":"2012","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"April (4)","key":"10.1016\/j.virusres.2016.12.008_bib0495","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/molbev\/msp289","article-title":"Phylogenetic analysis of population-based and deep sequencing data to identify coevolving sites in the nef gene of HIV-1","volume":"27","author":"Poon","year":"2010","journal-title":"Mol. Biol. Evol."},{"issue":"October (16)","key":"10.1016\/j.virusres.2016.12.008_bib0500","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1097\/QAD.0b013e32834b643c","article-title":"Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data","volume":"25","author":"Poon","year":"2011","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.virusres.2016.12.008_bib0505","doi-asserted-by":"crossref","first-page":"e1002753","DOI":"10.1371\/journal.pcbi.1002753","article-title":"Reconstructing the dynamics of HIV evolution within hosts from serial deep sequence data","volume":"8","author":"Poon","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.virusres.2016.12.008_bib0510","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/1471-2164-13-341","article-title":"A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers","volume":"13","author":"Quail","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.virusres.2016.12.008_bib0515","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jviromet.2014.11.003","article-title":"Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory","volume":"212","author":"Ram","year":"2015","journal-title":"J. Virol. Methods"},{"issue":"8","key":"10.1016\/j.virusres.2016.12.008_bib0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ng.3036","article-title":"Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications","volume":"46","author":"Rimmer","year":"2014","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.virusres.2016.12.008_bib0525","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00002030-198907000-00001","article-title":"Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy","volume":"3","author":"Rooke","year":"1989","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.virusres.2016.12.008_bib0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0040294","article-title":"Limitations of the human reference genome for personalized genomics","volume":"7","author":"Rosenfeld","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0535","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/aid.2009.0189","article-title":"Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir\/emtricitabine in antiretroviral-naive HIV-infected patients","volume":"26","author":"Ross","year":"2010","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0540","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1128\/AAC.00091-11","article-title":"Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism","volume":"55","author":"Saliou","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0545","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1086\/496984","article-title":"Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis","volume":"41","author":"Sax","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0550","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/bib\/bbs081","article-title":"Benchmarking of viral haplotype reconstruction programmes: an overview of the capacities and limitations of currently available programmes","volume":"15","author":"Schirmer","year":"2014","journal-title":"Brief. Bioinform."},{"issue":"March (6)","key":"10.1016\/j.virusres.2016.12.008_bib0555","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/nar\/gku1341","article-title":"Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform","volume":"43","author":"Schirmer","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virusres.2016.12.008_bib0560","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12859-016-0976-y","article-title":"Illumina error profiles: resolving fine-scale variation in metagenomic sequencing data","volume":"17","author":"Schirmer","year":"2016","journal-title":"BMC Bioinf."},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0565","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/088922202753472801","article-title":"Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program","volume":"18","author":"Schuurman","year":"2002","journal-title":"AIDS Res. Hum. Retroviruses"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0570","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jmb.2015.12.012","article-title":"A comprehensive analysis of primer IDs to study heterogeneous HIV-1 populations","volume":"428","author":"Seifert","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virusres.2016.12.008_bib0575","series-title":"21st Conference on Retroviruses and Opportunistic Infections","article-title":"Characterization of NNRTI mutations in HIV-1 RT using single molecule, real-Time SMRT\u00ae sequencing","author":"Sethuraman","year":"2014"},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0580","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-0934(00)00144-0","article-title":"Reproducibility of human immunodeficiency virus type 1 (HIV-1) protease and reverse transcriptase sequencing of plasma samples from heavily treated HIV-1-infected individuals","volume":"86","author":"Shafer","year":"2000","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0585","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4690-10-18","article-title":"Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of low-frequency drug resistance mutations in HIV-1 DNA","volume":"10","author":"Shao","year":"2013","journal-title":"Retrovirology"},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0590","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1073\/pnas.92.6.2398","article-title":"Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides","volume":"92","author":"Shirasaka","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0595","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1086\/596736","article-title":"Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes","volume":"199","author":"Simen","year":"2009","journal-title":"J. Infect Dis."},{"issue":"10","key":"10.1016\/j.virusres.2016.12.008_bib0600","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/JCM.00814-07","article-title":"Feasibility of detecting human immunodeficiency virus type 1 drug resistance in DNA extracted from whole blood or dried blood spots","volume":"45","author":"Steegen","year":"2007","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0605","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/QAI.0b013e3181d0558f","article-title":"Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and deep sequencing to plasma RNA and proviral DNA","volume":"54","author":"Swenson","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0610","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jiq030","article-title":"Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients","volume":"203","author":"Swenson","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virusres.2016.12.008_bib0615","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/cid\/cir493","article-title":"Deep V3 sequencing for HIV type 1 tropism in treatment-naive patients: a reanalysis of the MERIT trial of maraviroc","volume":"53","author":"Swenson","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"June (11)","key":"10.1016\/j.virusres.2016.12.008_bib0620","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1093\/cid\/cit105","article-title":"Use of cellular HIV DNA to predict virologic response to maraviroc: performance of population-based and deep sequencing","volume":"56","author":"Swenson","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virusres.2016.12.008_bib0625","series-title":"21st Conference on Retroviruses and Opportunistic Infections","article-title":"Tropism testing by MiSeq is comparable to 454-Based methods but exhibits contamination issues","author":"Swenson","year":"2014"},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0630","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/QAI.0b013e318189a753","article-title":"The relationship between resistance and adherence in drug-naive individuals initiating HAART is specific to individual drug classes","volume":"49","author":"Tam","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0635","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.2010.1004","article-title":"Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society USA panel","volume":"304","author":"Thompson","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0640","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00002030-200201250-00010","article-title":"Clinical utility of HIV-1 genotyping and expert advice: the Havana trial","volume":"16","author":"Tural","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.virusres.2016.12.008_bib0645","unstructured":"UNAIDS. 90-90-90 An ambitious treatment target to help end the AIDS epidemic. 2014."},{"key":"10.1016\/j.virusres.2016.12.008_bib0650","series-title":"Optimizing FDA\u2019s Regulatory Oversight of Next Generation Sequencing Diagnostic Tests \u2014 Preliminary Discussion Paper","author":"US Food and Drug Administration","year":"2015"},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0655","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-6405-7-4","article-title":"HIV-1 V3 envelope deep sequencing for clinical plasma specimens failing in phenotypic tropism assays","volume":"7","author":"Vandenbroucke","year":"2010","journal-title":"AIDS Res. Ther."},{"issue":"18","key":"10.1016\/j.virusres.2016.12.008_bib0660","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1097\/QAD.0000000000000502","article-title":"Emerging antiretroviral drug resistance in sub-Saharan Africa","volume":"28","author":"van Zyl","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.virusres.2016.12.008_bib0665","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/QAI.0b013e3181bca669","article-title":"Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors","volume":"52","author":"Varghese","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0670","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/bioinformatics\/btu587","article-title":"VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering","volume":"31","author":"Verbist","year":"2015","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.virusres.2016.12.008_bib0675","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1373\/clinchem.2008.112789","article-title":"Next-generation sequencing: from basic research to diagnostics","volume":"55","author":"Voelkerding","year":"2009","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.virusres.2016.12.008_bib0680","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1101\/gr.6468307","article-title":"Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance","volume":"17","author":"Wang","year":"2007","journal-title":"Genome Res."},{"issue":"19","key":"10.1016\/j.virusres.2016.12.008_bib0685","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gkr599","article-title":"SNVer: a statistical tool for variant calling in analysis of pooled or individual next-generation sequencing data","volume":"39","author":"Wei","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"March (6)","key":"10.1016\/j.virusres.2016.12.008_bib0690","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-134-6-200103200-00008","article-title":"Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness","volume":"134","author":"Weinstein","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"22","key":"10.1016\/j.virusres.2016.12.008_bib0695","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1093\/nar\/gks918","article-title":"LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets","volume":"40","author":"Wilm","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.virusres.2016.12.008_bib0700","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/JCM.06689-11","article-title":"Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool","volume":"50","author":"Woods","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"5","key":"10.1016\/j.virusres.2016.12.008_bib0705","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1128\/JVI.01396-10","article-title":"Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing","volume":"85","author":"Wright","year":"2011","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2016.12.008_bib0710","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1128\/JCM.00564-10","article-title":"Development and application of a broadly sensitive dried-blood-spot-based genotyping assay for global surveillance of HIV-1 drug resistance","volume":"48","author":"Yang","year":"2010","journal-title":"J. Clin. Microbiol."},{"issue":"12","key":"10.1016\/j.virusres.2016.12.008_bib0715","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1093\/nar\/gku392","article-title":"Performance comparison of SNP detection tools with Illumina exome sequencing data \u2212 an assessment using both family pedigree information and sample-matched SNP array data","volume":"42","author":"Yi","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0720","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1471-2105-14-274","article-title":"Comparing a few SNP calling algorithms using low-coverage sequencing data","volume":"14","author":"Yu","year":"2013","journal-title":"BMC Bioinf."},{"issue":"21","key":"10.1016\/j.virusres.2016.12.008_bib0725","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.1093\/nar\/gkq655","article-title":"Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies","volume":"38","author":"Zagordi","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.virusres.2016.12.008_bib0730","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2105-12-119","article-title":"ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data","volume":"12","author":"Zagordi","year":"2011","journal-title":"BMC Bioinf."},{"issue":"2","key":"10.1016\/j.virusres.2016.12.008_bib0735","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000332008","article-title":"Predicting response to antiretroviral treatment by machine learning: the EuResist project","volume":"55","author":"Zazzi","year":"2012","journal-title":"Intervirology"},{"issue":"16","key":"10.1016\/j.virusres.2016.12.008_bib0740","doi-asserted-by":"crossref","first-page":"8540","DOI":"10.1128\/JVI.00522-15","article-title":"Primer ID validates template sampling depth and greatly reduces the error rate of next-generation sequencing of HIV-1 genomic RNA populations","volume":"89","author":"Zhou","year":"2015","journal-title":"J. Virol."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216305974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216305974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,17]],"date-time":"2022-07-17T14:47:48Z","timestamp":1658069268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170216305974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":148,"alternative-id":["S0168170216305974"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2016.12.008","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promises and pitfalls of Illumina sequencing for HIV resistance genotyping","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}